Synergistic effect of diosmin and interferon-alpha on metastatic pulmonary melanoma

Nuria Alvarez1, Vicente Vicente, Cristina Martínez

  • 1University of Murcia Institute of Research into Aging, Department of Pathology, Faculty of Medicine, University of Murcia, Murcia, Spain. nalvarez@um.es

Insights

Combining the flavonoid diosmin with interferon-alpha (IFN-alpha) showed synergistic effects against metastatic melanoma in mice. This combination therapy offers a promising, less toxic approach to treating advanced skin cancer.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Research

Background:

  • Melanoma is a significant cause of cancer mortality, often metastasizing.
  • Interferon-alpha (IFN-alpha) is a toxic but established treatment for melanoma.
  • There is a need for less toxic melanoma therapies, including natural compounds like flavonoids.

Purpose of the Study:

  • To investigate the combined therapeutic effects of IFN-alpha and the flavonoid diosmin.
  • To evaluate this combination therapy in a murine model of metastatic B16F10 melanoma.
  • To assess both macroscopic and microscopic outcomes of the combined treatment.

Main Methods:

  • Utilized a murine model of metastatic B16F10 melanoma.
  • Administered combined treatment with IFN-alpha and diosmin.
  • Assessed treatment efficacy macroscopically by counting subpleural nodules.
  • Evaluated outcomes microscopically using image analysis to calculate specific indices.

Main Results:

  • IFN-alpha demonstrated dose-dependent anti-invasive and antiproliferative activity.
  • Diosmin exhibited anti-invasive activity comparable to a low dose of IFN-alpha.
  • A synergistic antiproliferative effect was observed when combining diosmin with the lowest dose of IFN-alpha, matching the efficacy of the highest IFN-alpha dose alone.

Conclusions:

  • The combination of diosmin and IFN-alpha exhibits synergistic antiproliferative effects in metastatic melanoma.
  • This combination therapy may offer a less toxic and effective treatment strategy for advanced melanoma.
  • Flavonoids like diosmin hold potential as adjuncts in melanoma treatment regimens.